Información del artículo
El Texto completo está disponible en PDF
Biblografía
[1.]
J.M. Sánchez-Tapias, J.M. Barrera, J. Costa, M.G. Ercilla, A. Pares, L. Comalrrena, et al.
Hepatitis C virus infection in non-alcoholic chronic liver disease.
Ann Intern Med, 112 (1990), pp. 921-924
[2.]
X. Forns, S. Ampurdanés.
Clínica de las hepatitis virales: Hepatitis aguda. Hepatitis crónica. Carcinoma hepatocelular.
Enferm Infec Microbiol, 13 (1995), pp. 71-83
[3.]
X. Forns, S. Ampurdanés, J.M. Sánchez-Tapias, M. Guilera, M. Sans, A. Sánchez-Fueyo, et al.
Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center.
J Hepatol, 35 (2001), pp. 265-271
[4.]
S. Ampurdanés, X. Forns, J.M. Sánchez-Tapias.
Tratamiento actual y perspectivas terapéuticas en la hepatitis crónica C.
Biblioteca de hepatitis,
[5.]
F.X. López-Labrador, S. Ampurdanés, X. Forns, A. Castells, J.C. Saiz, J. Costa, et al.
Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma.
J Hepatol, 27 (1997), pp. 959-965
[6.]
T. Poynard, P. Marcellin, S.S. Lee, C. Niederau, G.S. Minuk, G. Ideo, et al.
Randomised trial of interferon a-2b plus ribavirin for 48 weeks versus interferon a-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus.
Lancet, 352 (1998), pp. 1426-1432
[7.]
M. Giménez-Barcons, A. Tajahuerce, J.C. Saiz.
Valor predictivo de diversos factores virales en la respuesta al tratamiento con interferón en pacientes con hepatitis crónica C.
Gastroenterol Hepatol, 21 (1998), pp. 404-412
[8.]
F.A. Murphy, C.M. Fauquet, D.H.L. Bishop, S.A. Ghabrial, A.W. Jarvis, G.P. Martelli, et al.
Classification and nomenclature of viruses: sixth report of the international commite on taxonomy of viruses.
pp. 424-426
[9.]
X. Forns, J. Bukh.
The molecular biology of hepatitis C virus. Genotypes and quasispecies.
Clin Liver Dis, 4 (1999), pp. 693-716
[10.]
K.E. Reed, C.M. Rice.
Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties.
Curr Top Microbiol Immunol, 242 (2000), pp. 55-84
[11.]
M. Martell, J.I. Esteban, J. Quer, J. Genesca, A. Weiner, R. Esteban, et al.
Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution.
J Virol, 66 (1992), pp. 3225-3229
[12.]
E. Domingo.
Virus en Evolución: una aproximación a la dinámica poblacional de los virus y al origen de nuevas enfermedades.
[13.]
E. Domingo, E. Baranowski, C.M. Ruiz-Jarabo, A.M. Martín-Hernández, J.C. Sáiz, C. Escaronis, et al.
Quasispecies structure and persistence of RNA viruses.
Emerg Infect Dis, 4 (1998), pp. 521-527
[14.]
X. Forns, R.H. Purcell, J. Bukh.
Quasispecies in viral persistence and pathogenesis of hepatitis C virus.
Trends Microbiol, 7 (1999), pp. 402-410
[15.]
R. Bartenschlager, V. Lohmann.
Replication of hepatitis C virus.
J Gen Virol, 81 (2000), pp. 1631-1648
[16.]
A. Grakoui, H.L. Hanson, C.M. Rice.
Bad time for Bonzo? Experimental models of hepatitis C virus infection, replication, and pathogenesis.
Hepatology, 33 (2001), pp. 489-495
[17.]
A.A. Kolykhalov, E.V. Agapov, K.J. Blight, K. Mihalik, S.M. Feinstone, C.M. Rice, et al.
Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA.
Science, 277 (1997), pp. 570-574
[18.]
M. Yanagi, R.H. Purcell, S.U. Emerson, J. Bukh, et al.
Transcript from a single full-lenght cDNA clone of hepatitis C virus are infectious in vivo.
Proc Natl Acad Sci USA, 94 (1997), pp. 8738-8743
[19.]
V. Lohmann, F. Korner, J. Koch, U. Herian, L. Theilmann, R. Bartenschlager, et al.
Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.
Science, 285 (1999), pp. 110-113
[20.]
K.J. Blight, A.A. Kolykhalov, C.M. Rice.
Efficient initiation of HCV RNA replication in cell culture.
Science, 290 (2000), pp. 1972-1974
[21.]
J.E. Reynolds, A. Kamisnki, H.J. Kettinen, K. Grace, B.E. Clarke, A.R. Carroll, et al.
Unique features of internal initiation of hepatitis C virus RNA translation.
EMBO J, 14 (1995), pp. 6010-6020
[22.]
R.J. Jackson.
A comparative view of initiation site selction mechanism.
Translational control, pp. 71-112
[23.]
C. Laxton, E. Hobbs, S. Fletcher, J.A. Symons, R. Bartenschlager, R. Graver, et al.
Use of the HCV subgenomic replicon for the selection and characterization of variants with reduced susceptibility to interferon alpha-2a.
J Hepatol, 34 (2001), pp. 15
[24.]
T. Pietschmann, V. Lohmann, G. Rutter, K. Kurpanek, R. Bartenschlager, et al.
Characterization of cell lines carrying self-replicating hepatitis C virus RNAs.
J Virol, 75 (2001), pp. 1252-1264
[25.]
V. Lohmann, F. Körner, A. Dobierzewska, R. Bartenschlager.
Mutations in hepatitis C virus RNAs conferring cell culture adaptation.
J Virol, 75 (2001), pp. 1437-1449
[26.]
N. Krieger, V. Lohmann, R. Bartenschlager.
Enhacement of hepatitis C virus RNA replication by cell culture-adptative mutations.
J Virol, 75 (2001), pp. 4614-4624
[27.]
J.M. Pawlotsky, G. Germanidis.
The non-structural 5A protein of hepatitis C virus.
J Viral Hepatol, 6 (1999), pp. 343-356
[28.]
N. Enomoto, I. Sakuma, Y. Asahina, M. Kurosaki, T. Murakami, C. Yamamoto, et al.
Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.
N Engl J Med, 334 (1996), pp. 77-81
[29.]
J.C. Saiz, F.X. López-Labrador, S. Ampurdanés, J. Dopazo, X. Forns, J.M. Sánchez-Tapias, J. Rodes.
The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus.
J Infect Dis, 177 (1998), pp. 839-847
[30.]
F. Puig-Basagoiti, J.C. Saiz, X. Forns, S. Ampurdanés, M. Giménez-Barcons, S. Franco, et al.
Influence of the genetic heterogeneity of the ISDR and PePHD regions of hepatitis C virus on the response to interferon therapy in chronic hepatitis C.
J Med Virol, (2001),
[31.]
G.W. Witherell, P. Beineke.
Statistical analysis of combined substitutions in nonstructural 5A region of hepatitis C virus and interferon response.
J Med Virol, 63 (2001), pp. 8-16
[32.]
J. Schinkel, W.J.M. Spaan, A.C.M. Kroes.
Mutations in the NS5A gene and hepatitis C virus resistance to interferon: solving the controversy.
J Hepatol, 34 (2001), pp. 117
[33.]
M.J. Gale Jr, M.J. Korth, N.M. Tang, S.L. Tan, D.A. Hopkins, T.E. Dever, et al.
Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein.
Virology, 230 (1997), pp. 217-227
[34.]
M. Giménez-Barcons, S. Franco, Y. Suárez, X. Forns, S. Ampurdanés, F. Puig-Basagoiti, et al.
High amino acid variability within the NS5A of Hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b related cirrhosis.
Hepatology, 34 (2001), pp. 158-167
Copyright © 2001. Elsevier España, S.L.. Todos los derechos reservados
